Диссертация (1174362), страница 33
Текст из файла (страница 33)
Deckers, S.C. Ribeiro, R.D.S. Simões, C. Miyahara, E.C.Baracat // Int J Gynaecol Obstet. – 2018. - No140 (1). Р. 11-17.189124.Dewailly, D. The physiology and clinical utility of anti-Mullerianhormone in women / D. Dewailly // Hum Reprod Update. – 2014. - No20(3).- Р:370–385.204125.Di Emidio, G. Increased levels of oxidative and carbonyl stress markersin normal ovarian cortex surrounding endometriotic cysts / G. Di Emidio, A.D'Alfonso, P.
Leocata // Gynecol Endocrinol. – 2014. - No30(11). – Р. 80812.126.Di Nisio, V. Increased levels of proapoptotic markers in normal ovariancortex surrounding small endometriotic cysts. Reprod Biol. – 2019. - No19(3).– P. 225-229.127.Di Tucci, M.L. Management of Endometriomas / M.L. Di Tucci, M.
diFeliciantonio, G. Galati, L. Verrelli, V. di Donato // Semin Reprod Med. –2017. - No35. – Р. 25-30.128.Dolleman, M. Reproductive and lifestyle determinants of antiMullerian hormone in a large population-based study / M. Dolleman, W.M.Vers churen, M.J. Eijkema ns, M.E. Dolle, E.H. Jansen, F.J. Broekmans, Y.T.van der Schouw // J Clin Endocrinol Metab. – 2013. - No98. – Р.2106–2115.129.Donnez, J. Ovarian endometriosis and fertility preservation: a challengein 2018/ J. Donnez, J. García-Solares, M.M. Dolmans // Minerva Ginecol.
–2018. -No70 (4). - Р.408-414.130.Dumont, A. Role of Anti-Müllerian Hormone in pathophysiology,diagnosis and treatment of Polycystic Ovary Syndrome: a review / A.Dumont, G. Robin, S. Jonard, D. Dewailly // Reprod Biol Endocrinol. – 2015.- No13 (1). – Р.137.131.Dunselman G.A. European Society of Human Reproduction andEmbryology. ESHRE guideline: management of women with endometriosis /G.A. Dunselman, N. Vermeulen, C. Becker, C. Calhaz-Jorge, T. D'Hooghe //Hum Reprod. - 2014. - No 29.
– Р.400-412.132.Drosdzol-Cop, A. Evaluation of the Ki-67 Proliferation Index andUrocortin Expression in Women with Ovarian Endometriomas. J ObstetGynaecol Res. – 2012. - No38(10).- P.1245-53.133.El-Mazny, A. Effect of ovarian endometrioma on uterine and ovarianblood flow in infertile women/Kamel A, Ramadan W, Gad-AllahS, Abdelaziz S, Hussein AM//Int J Womens Health. – 2016. - No28;8.
– P.677-682. eCollection 2016.134.Esinler, I.E . Endometrioma <3 cm in Diameter per se Does Not AffectOvarian Reserve in Intracytoplasmic Sperm Injection Cycles Gynecol ObstetInvest.- 2012. - No74(1). – P. 261–264135.ESHRE Guideline Group on Good Practice in IVF Labs, De losSantos MJ, Apter S,Coticchio G, Debrock S, Lundin K, et al. Revised205guidelines for good practice in IVF laboratories (2015). Hum Reprod.
–2016. – No. 31(4). – P.685-6.136.Errázuriz, V.J. Association between antral follicle count and age infertile women / V.J. Errázuriz, Á. Carrasco, R.E. Díaz, R.P. Sanhueza, S.P.González, P.P. Donoso // Rev Med Chil. – 2017. - No145 (6). – Р.741-746.137.Evans, M.B. Fertility and Endometriosis / M.B. Evans, A.H. Decherney// Clin Obstet Gynecol. 2017. - No60 (3). – Р.497-502.138.Exacoustos, C. Imaging for the evaluation of endometriosis andadenomyosis / C.
Exacoustos, L. Manganaro, E. Zupi // Best Pract Res ClinObstet Gynaecol. – 2014. - No28 (5). – Р.655-81.139.Falcone,T.Surgical Treatment of Endometriosis: Excision Versus Ablation of Peritoneal Disease/ Wilson J.R.//J Minim Invasive Gynecol.- 2019. –No.26(1). – P.1-2.140.Falcone, T. Clinical Management of Endometriosis / T.
Falcone, R.Flyckt // Obstet Gynecol. – 2018. - No131 (3). – Р.557-571.141.Fiala,L.Oncologicalmarkers CA-125,CA19-9and endometriosis/Bob P, Raboch J//Medicine (Baltimore). 2018. –No.97(51). P. e13759.142.Flyckt,R.Surgical Management of Endometriosis in Patients with Chronic Pelvic Pain.Semin Reprod Med. -2017. - No35(1).- P.54-64.143.Freeman E.W. Anti-mullerian hormone as a predictor of time tomenopause in late reproductive age women / E.W.
Freeman, M.D. Sammel,H.Lin., C.R. Gracia // J Clin Endocrinol Metab . – 2012. - No97 (5). – Р. 167380.144.Gajbhiye R, Bendigeri T, Ghuge A, Bhusane K, Begum S, Warty N,Sawant R, Padte K, Humane A, Dasmahapatra P, Chauhan A, Khan S. Panelof Autoimmune Markers for Noninvasive Diagnosis of Minimal-MildEndometriosis. Reprod Sci. 2017 Mar;24(3):413-420.145.García-Tejedor, A. Ethanol sclerotherapy of ovarian endometrioma: asafe and effective minimal invasive procedure. Preliminary results/Castellarnau M, Ponce J, Fernández ME, Burdio F//Eur J Obstet GynecolReprod Biol.
– 2015. – No.187. – P.25-9.134.146.Garcia-Velasco, J.A. Management of endometriomas in womenrequiring IVF: to touch or not to touch / J.A. Garcia-Velasco, E. Somigliana// Hum Reprod. – 2009. - No 24. – Р.496-501.206147.Georgievska, J. Effect of two laparoscopic techniques for treatment ofovarian endometrioma on ovarian reserve. Med Arch.- 2015.- No 69(2).
–P.88-90.148.Giampaolino, P. Endometrioma size is a relevant factor in selection ofthe most appropriate surgical technique: a prospective randomizedpreliminary study. Eur J Obstet. Gynecol. Reprod. Biol.- 2015. - No195. –P.88-93149.Giudice, L.C. Endometriosis / L.C. Giudice, L. Kao // The Lancet. –2006. - No364. – Р.1789-1799.150.Johnson, N.P. World Endometriosis Society Montpellier Consortium.Consensus on current management of endometriosis / N.P.
Johnson, L.Hummelshoj // Hum. Reprod. - 2013. – Vol. 28. - № 6. - P. 1552-1568.151.Gracia, C.R. Multi-center clinical evaluation of the Access AMH assayto determine AMH levels in reproductive age women during normalmenstrual cycles / C.R. Gracia, S.S. Shin, M.
Prewitt // J Assist Reprod Genet.– 2018. - No35 (5). – Р.777-783.152.Greene, A.D. Endometriosis: where are we and where are we going?Reproduction. -2016. - No152(3). – P. 63-78.153.Guerriero, S. Age-related differences in the sonographic characteristicsof endometriomas / S. Guerriero , B. Van Calster, E. Somigliana, S.
Ajossa //Hum Reprod. - 2016. - No31 (8). – Р.1723-31.154.Guler, I. The Impact of laparoscopic surgery of peritonealendometriosis and endometrioma on the outcome of ICSI cycles / I. Guler, A.Erdem, Y. Oguz, F. Cevher, M.F. Mutlu, N. Bozkurt, M. Oktem, M. Erdem //Syst Biol Reprod Med. – 2017. - No63(5). – Р.324-330.155.Hart, R. Excisional surgery versus ablative surgery for ovarianendometriomata: a Cochrane Review/ Hickey M, Panos M , Buckett W,Garry R// Human Reproduction . – 2005. - No.11. - pp.
3000–3007156.Harlev, A. Targeting oxidative stress to treat endometriosis / A. Harlev,S. Gupta, A. Agarwal // Expert Opinion on Therapeutic Targets. – 2015. - Vol.19. - No11. – P.1447–1464.157.Henes M. Ovarian cyst removal influences ovarian reserve dependenton histology, size and type of operation / M. Henes, T. Engler, F.A.Taran, S.Brucker, K. Rall, B.Janz, Lawrenz B.
// Womens Health (Lond). - 2018158.Hwu Y.M. The impact of endometrioma and laparoscopic cystectomyon serum anti-Müllerian hormone levels / Y.M. Hwu, F.S.Wu, S.H. Li, F.J.Sun, M.H.Lin, R.K. Lee // Reprod Biol Endocrinol. – 2011. - No9. – Р.80.207159.Hvidman H.W. Anti-Müllerian hormone levels and fecundability inwomen with a natural conception / H.W. Hvidman, A.K. Bang, L. Priskorn //Eur J Obstet Gynecol Reprod Biol. – 2017. - No17.
– Р.44-52.160.Ito, F. Role of oxidative stress in epigenetic modification inendometriosis / F. Ito, Y.Yamada, A. Shigemitsu // Reproductive Sciences. –2017. -Vol. 60. – P.11-113.161.Iwase, A. Serum anti-Müllerian hormone level is a useful marker forevaluating the impact of laparoscopic cystectomy on ovarian reserve / A.Iwase, W. Hirokawa, M. Goto // Fertil Steril. – 2010. - No94. – Р.2846–2849.162.Iwabuchi, T. Oxidative stress and antioxidant defense in endometriosisand its malignant transformation / T. Iwabuchi, C. Yoshimoto, H. Shigetomi// Oxidative Medicine and Cellular Longevity.
– 2015. – Р.7.163.Iwase, A. Clinical application of serum anti-Müllerian hormone as anovarian reserve marker: A review of recent studies / A.Iwase, S.Osuka,M.Goto, T.Murase, T.Nakamura, S.Takikawa, F. Kikkawa // J ObstetGynaecol Res. – 2018. - No44(6). – Р.998-1006.164.Jayaprakasan, K.
The effect of surgery for endometriomas on fertility:scientific impact paper/ Becker C, Mittal M. //BJOG.- 2018.- No125.- P.19–28.165.Jia, M. Estrogen receptor alpha and beta in health anddisease/Dahlman-Wright K, Gustafsson JÅ//Best Pract Res Clin EndocrinolMetab.- 2015/ - No.29(4). P. 557-68.166.Jones K.D. Recurrence of chocolate cysts after lapаroscopic ablation /K.D.Jones, C.J. Sutton // J Am Assoc Gynecol Laprosc.
- 2002. - No 9. –Р.315-320.167.Johnstone, E.B. Controversies in the Management of Endometrioma:To Cure Sometimes, to Treat Often, to Comfort Always?/ Link M.H//ClinObstet Gynecol.- 2015. – No.58(4). - P.754-64.168.Kahyaoglu, I. Comparison of Ki-67 proliferative index between eutopicand ectopic endometrium: a case control study / I. Kahyaoglu, S.Kahyaoglu,O.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
